News

FDA panel endorses teplizumab for delaying type 1 diabetes
- Author:
- Miriam E. Tucker
Publish date: May 28, 2021
News
‘Overbasalization’ common in type 2 diabetes management
- Author:
- Miriam E. Tucker
Publish date: May 26, 2021
News
Mild cortisol excess increases mortality in adrenal incidentaloma
- Author:
- Miriam E. Tucker
Publish date: May 25, 2021
News
Obesity hope as neuropeptide Y blocker turns white fat to brown
- Author:
- Miriam E. Tucker
Publish date: May 24, 2021
News
FDA clears cap device for ‘smart’ insulin pens for diabetes
- Author:
- Miriam E. Tucker
Publish date: May 11, 2021
News
In-hospital glucose management program gives dramatic savings
- Author:
- Miriam E. Tucker
Publish date: May 10, 2021
Opinion
Dr. Topol talks: COVID-19 variants are innocent until proven guilty
- Author:
- Miriam E. Tucker
Publish date: May 7, 2021
News

Only a third of adults with diabetes receive ADA-recommended care
- Author:
- Miriam E. Tucker
Publish date: May 6, 2021
News
Most kids with type 1 diabetes and COVID-19 in U.S. fared well
- Author:
- Miriam E. Tucker
Publish date: May 3, 2021
News

Promising data on once-weekly insulin, phase 3 study ongoing
- Author:
- Miriam E. Tucker
Publish date: April 26, 2021
News
Cushing’s death rate ‘unacceptable,’ triple that of general population
- Author:
- Miriam E. Tucker
Publish date: April 21, 2021
News

FDA panel supports islet cell treatment for type 1 diabetes
- Author:
- Miriam E. Tucker
Publish date: April 16, 2021
News
Fit-for-Fertility program boosts births, is cost effective
- Author:
- Miriam E. Tucker
Publish date: April 8, 2021
News

FDA approves new ready-to-inject glucagon product
- Author:
- Miriam E. Tucker
Publish date: April 2, 2021
News
CDC adds new medical conditions to COVID-19 high-risk list
- Author:
- Miriam E. Tucker
Publish date: March 31, 2021